Welcome to our dedicated page for Iqvia Hldgs SEC filings (Ticker: IQV), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Tracking how IQVIA turns billions of clinical data points into revenue can feel like decoding a medical registry. Key figures on contract research backlogs, technology licensing, and goodwill impairment are scattered across dense reports, and keeping up with IQVIA insider trading Form 4 transactions adds another layer of complexity. Investors who type “IQVIA SEC filings explained simply” need more than raw documents—they need answers. Stock Titan’s AI reads every line the moment it hits EDGAR and highlights what matters.
Whether you’re hunting for the latest IQVIA quarterly earnings report 10-Q filing, comparing cash-flow trends inside an IQVIA annual report 10-K simplified, or needing IQVIA Form 4 insider transactions real-time, our platform delivers. We pair line-by-line machine learning with human-trained models, turning raw data into plain-English takeaways. Drill into revenue by segment, R&D capitalization, or debt covenants in seconds—understanding IQVIA SEC documents with AI becomes straightforward. Each page also links to thorough IQVIA earnings report filing analysis prepared by our research desk, so you can move from numbers to narrative without opening a spreadsheet.
Looking beyond quarterly results, Stock Titan monitors every event that could move the share price. Receive instant alerts when IQVIA 8-K material events explained—think acquisitions, data breaches, or leadership changes—are posted. Explore IQVIA executive stock transactions Form 4 to gauge management sentiment, and review the IQVIA proxy statement executive compensation section to see how performance metrics align with pay. With real-time updates, AI-powered summaries, and historical search across all forms, you’ll spend less time digging and more time deciding.
Old National Bancorp (NASDAQ: ONB) filed an 8-K dated July 22, 2025. Under Item 2.02, the company states it has issued a press release reporting second-quarter 2025 financial results; the release is furnished as Exhibit 99.1 and incorporated by reference.
Management will host an earnings conference call on July 22 at 9:00 a.m. CDT. A slide presentation covering Q2 results, strategic developments and outlook will be posted to the Investor Relations section of the company’s website immediately before the call. The filing itself contains no quantitative metrics.
The document also lists the company’s registered securities (common stock; Series A & C preferred depositary shares) and includes the standard Inline XBRL cover-page file. No other material events were disclosed.
FAQ
What is the current stock price of Iqvia Hldgs (IQV)?
What is the market cap of Iqvia Hldgs (IQV)?
What is the core business of IQVIA?
How did IQVIA come into existence?
What are the primary segments of IQVIA's business?
How does IQVIA maintain data privacy and security?
Who are the main customers of IQVIA?
How does IQVIA integrate technology with its clinical trials?
What differentiates IQVIA in the competitive healthcare market?
